Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rong Huang has a total of 140 co-authors. Here are the top co-authors by number of shared publications:

  • Ji-Kai Liu

    South-Central Minzu University

    9 shared publications
  • Si-Yong Qin

    Hubei Engineering Technology Research Centre of Energy Polymer Materials, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, China; Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, China

    5 shared publications
  • Wen-Long Liu

    Hubei Engineering Technology Research Centre of Energy Polymer Materials, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, China

    5 shared publications
  • Xiang Zhou

    College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, China

    5 shared publications
  • Shengyong Yan

    College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Hubei, Wuhan, 430072, PR China

    4 shared publications
  • Xiaocheng Weng

    College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, State Key Laboratory of Virology, Wuhan University, Hubei, Wuhan, P. R. China

    4 shared publications

Latest Publications

  • Open Access

    Grifolin Exhibits Promising Antimicrobial Potential Against MRSA Infection

    by Guosheng Hu, Yun Zhou, Mengxi Wang, Rong Huang, Jikai Liu

    Methicillin-resistant Staphylococcus aureus (MRSA) exhibits widespread multidrug resistance and frequently causes refractory wound infections, particularly in diabetic patients, creating an urgent need for new therapeutic options. Grifolin, a naturally occurring phenolic compound with antibacterial, anti-inflammatory, and antioxidant activities, represents a promising candidate for the comprehensive treatment of infected diabetic wounds. Herein, we systematically investigated the antibacterial activity and mechanism of grifolin against MRSA, as well as its therapeutic efficacy in a murine model of MRSA-infected diabetic wounds. In vitro, grifolin exhibited potent antibacterial activity against MRSA (MIC = 3 μg/mL, MBC = 4 μg/mL), effectively eliminated mature biofilms, and potentiated conventional antibiotics. Integrated transcriptomic and proteomic analyses, corroborated by qRT-PCR, revealed coordinated changes in membrane integrity, translation and metabolism, and quorum sensing and virulence. In vivo, grifolin significantly reduced the wound bacterial burden, suppressed the expression of pro-inflammatory cytokines IL-6 and TNF-α, promoted angiogenesis and tissue remodeling, and accelerated diabetic wound healing with favorable preliminary tolerability. This study highlights grifolin as a promising lead compound for combating MRSA infections and treating associated diabetic wound complications.

  • Discovery of Cbl-b Targeting Cyclic Peptide Ligands by Phage Display

    by Xiao-Qin Yang, Wei Ming, Wei-Kang Zhai, Rong Huang, Zheng-Hui Li, Kai Li, Li-Wen Bai, Xinxiang Lei

    Cbl-b is a RING-type E3 ubiquitin ligase and intracellular immune checkpoint that negatively regulates immune-cell activation. However, ligand discovery for Cbl-b remains limited, largely because the RING-type E3 ubiquitin ligase is regulated by shallow and extended protein–protein interaction interfaces that are difficult to target with conventional small molecules. Here, we employed a genetically encoded, macrocyclization-enabled phage-display library incorporating the cysteine-reactive noncanonical amino acid O2beY to identify cyclic peptide ligands for Cbl-b. Affinity selection followed by biolayer interferometry revealed a macrocyclic peptide binder with a dissociation constant of Kd = 798 ± 50 nM. These results highlight the ability of conformationally constrained macrocyclic scaffolds to engage challenging Cbl-b surfaces and provide a peptide-based starting point for developing chemical probes targeting Cbl-b-regulated ubiquitin signaling.

  • Open Access

    Isothiocyanate-mediated cyclization of phage-displayed peptides enables discovery of macrocyclic binders

    by Liwen Bai, Ting Dan, Peng Cheng, Xiaoqin Yang, Hua Xiang, Weikang Zhai, Yifei Chen, Rong Huang, Qi Wang, Kai Li, et al.

    Cyclic peptides exhibit advantages in binding protein targets with high affinity and competency in inhibiting protein-protein interactions. Cyclic peptide phage display with more than a billion variants is an invaluable tool in drug discovery. However, achieving efficient peptide cyclization on phages remains a challenge because of the limited availability of reaction sites, which also restrict scaffold diversity. Here, we report an isothiocyanate-derived cross-linker featuring dual reactive groups: a bromide that covalently attaches to cysteine thiols and a thiocyanogen that selectively forms a thiourea bridge with either the N-terminal amino group or ε-amines of lysine, depending on pH. This strategy enables pH-modulated cyclization. At pH 6.5, head–to–side chain cyclization occurs, and at pH 9.5, side chain–to–side chain ligation is performed. Both processes simultaneously generate thiourea scaffolds. To demonstrate the versatility and biocompatibility of this approach, we constructed cyclic peptide libraries using both cyclization methods and successfully selected binders for several targets, including cyclophilin D, murine double minute 2, and Keap1, with dissociation constants ranging from micromolar to nanomolar. Given the broad pharmacological potential of the thiourea moiety, this phage display library opens previously unidentified chemical space with high scaffold diversity and the integration of a proven pharmacophore for the development of cyclic peptide therapeutics.


  • Open Access

    Novel Tyrosinase and α-Glucosidase Inhibitors: 1,3-Bisbenzylphenylphenol and Congeners as Cosmetic Whitening Agents Based on Natural Products

    by Meng-Fei Wanyan, Xing Wu, Hui-Xiang Yang, Liang Tu, Qian Chen, Zhi-Hui Dong, Yu-Ting Tian, Xiao Lv, Qiong Chen, Hui-Hui Shen, et al.

    New diarylheptene polyphenols with α-glucosidase inhibitory activity were previously isolated and reported from the aquatic plant Ottelia acuminata var. acuminata. It was used as the template in the present research, and a series of 1,3-bisbenzylphenylphenolic compounds were designed and synthesized. The tyrosinase, α-glucosidase inhibitory effects, antioxidant properties, and whitening effects of these compounds were investigated. Of them, the representative compounds 1 and 2 inhibited the two target enzymes (tyrosinase and α-glucosidase) engaged in skin whitening and aging with comparable IC50 values to the reference drugs as well as antioxidant activities. They showed potent whitening efficacy in zebrafish. In particular, compound 1 had whitening-effect rates of 31% at a concentration of 0.0001% (m/m), and 52% at a concentration of 0.0002% (m/m). Both compounds had more superior whitening efficacy than the commercially available whitening agent phenylethylresorcinol (377), which was used as a positive control. Compounds 1 and 2 did not show any genotoxicity and skin phototoxicity at the test concentrations, and they show promise as new skin-whitening agents.


  • Bacterial membrane-anchored lipopeptide/MXene nanoplatform for tri-modal therapy toward bacteria-infected diabetic wound

    by Ding-Yi Zhang, Meng-Xi Wang, Chuang Cai, Wei-Wei Cheng, Yin-Jia Cheng, Wen-Long Liu, Rong Huang, Ai-Qing Zhang, Si-Yong Qin


  • Open Access

    Cuphea hookeriana: Phytochemical Profile and the Cosmeceutical and Dermatological Properties of Its Active Fraction from the Whole Plant

    by Xing Wu, Meng-Fei Wanyan, Bao-Bao Shi, Rong Huang, Hui-Xiang Yang, Xian Wang, Ji-Kai Liu

    Natural products and botanicals continue to play a very important role in the development of cosmetics worldwide. The chemical constituents of a fine active fraction of the whole plant extract of Cuphea hookeriana Walp., and the tyrosinase and matrix metalloproteinase-1 (MMP-1) inhibitory and antioxidant activities of this fraction were investigated. The fine active fraction was mainly composed of seven natural compounds. The fine active fraction demonstrated substantial in vitro antioxidant potential using the ABTS assay (IC50 1.66 μg/mL). It inhibited the two target enzymes (tyrosinase and MMP-1) engaged in skin whitening and aging with comparable IC50 values to the reference drugs. Acute toxicity experiments showed that mice gavage orally with the fine active fraction had no significant animal toxicity at a dose of 2000 mg/kg, and the maximum tolerated dose (MTD) in mice was greater than 2000 mg/kg. In a model where ultraviolet light promotes the increase in melanin secretion in guinea pig skin tissues, both α-arbutin and the fine active fraction can reduce melanogenesis, and the effect of the fine active fraction is better than that of α-arbutin.


  • Open Access

    Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

    by Xinxiang Lei, Liwen Bai, Ting Dan, Peng Cheng, Xiaoqin Yang, Hua Xiang, Rong Huang, Qi Wang, Kai Li, JinMing Gao

    Cyclic peptides exhibit advantages in binding protein targets with high affinity and competency in inhibiting protein-protein interactions (PPIs). Cyclic peptide phage display with over a billion variants is an invaluable tool in drug discovery. However, achieving efficient peptide cyclization on phages remains a challenge due to the limited availability of reaction sites, which also restricts scaffold diversity. Here, we report an isothiocyanate-derived crosslinker featuring dual reactive groups: a bro-mide that covalently attaches to cysteine thiols, and a thiocyanogen that selectively forms a thiourea bridge with either the N-terminal amino group or ε-amines of lysine, depending on pH. This strategy enables pH-modulated cyclization, with head-to-side chain cyclization at pH 6.5 and side chain-to-side chain ligation at pH 9.5, simultaneously generating thiourea scaffolds. To demonstrate the versatility and biocompatibility of this approach, we constructed cyclic peptide libraries using both cy-clization methods and successfully selected binders for several targets, including Cyp D, TNF, MDM2, and Keap1, with disso-ciation constants (KD) ranging from micromolar to nanomolar. Given the broad pharmacological potential of the thiourea moiety, this phage display library opens new chemical space with high scaffold diversity and the integration of a proven pharmacophore for the development of cyclic peptide therapeutics.


  • Open Access

    Bactericidal and biofilm eradication efficacy of a fluorinated benzimidazole derivative, TFBZ, against methicillin-resistant Staphylococcus aureus

    by Qian Chen, Zhihui Dong, Xuedi Yao, Huan Sun, Xin Pan, Jikai Liu, Rong Huang

    Methicillin-resistant Staphylococcus aureus (MRSA) is a major inducement of nosocomial infections and its biofilm formation render the high tolerance to conventional antibiotics, which highlights the requirement to develop new antimicrobial agents urgently. In this study, we identified a fluorinated benzimidazole derivative, TFBZ, with potent antibacterial efficacy toward planktonic MRSA (MIC = 4 μg/mL, MBC = 8 μg/mL) and its persistent biofilms (≥99%, MBEC = 8 μg/mL). TFBZ manifested significant irreversible time-dependent killing against MRSA as characterized by diminished cell viability, bacterial morphological change and protein leakage. Furthermore, the results from CBD devices, crystal violet assay in conjunction with live/dead staining and scanning electron microscopy confirmed that TFBZ was capable of eradicating preformed MRSA biofilms with high efficiency. Simultaneously, TFBZ reduced the bacterial invasiveness and exerted negligible hemolysis and cytotoxicity toward mammalian cells, which ensuring the robust therapeutic effect on mouse skin abscess model. The transcriptome profiling and quantitative RT-PCR revealed that a set of encoding genes associated with cell adhesion, biofilm formation, translation process, cell wall biosynthesis was consistently downregulated in MRSA biofilms upon exposure to TFBZ. In conclusion, TFBZ holds promise as a valuable candidate for therapeutic applications against MRSA chronic infections.


  • Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles

    by Hui Guo, Yuqi Tian, Xing Wu, Liang Tu, Jikai Liu, Yongsheng Zheng, Rong Huang